Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay

By Constenla Dagna O.  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 24, Iss. 2, 2008-08 ,pp. : 101-112

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Cost-effectiveness of pneumococcal conjugate vaccination in Latin America and the Caribbean: a regional analysis

By Sinha Anushua   Constenla Dagna   Valencia Juan Esteban   O'Loughlin Rosalyn   Gomez Elizabeth   de la Hoz Fernando   Valenzuela Maria Teresa   de Quadros Ciro A.  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 24, Iss. 5, 2008-11 ,pp. : 304-313

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

By Bergman Annika   Hjelmgren Jonas   Ortqvist Åke   Wisløff Torbjørn   Sønbø Kristiansen Ivar   Diaz Hogberg Liselotte   M-S Persson Kristina   Persson Ulf  

Scandinavian Journal of Infectious Diseases, Vol. 40, Iss. 9, 2008-01 ,pp. : 721-729

Informa Healthcare

Access to resources Recommend Favorite

Proposed pneumococcal vaccination for children

By Moreton Judith   Bedford Helen  

Community Practitioner, Vol. 78, Iss. 3, 2005-03 ,pp. : 114-114

Community Practitioner

Access to resources Recommend Favorite

Economic impact of 13‐valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions

By  

JOURNAL OF EVALUATION IN CLINICAL PRACTICE (ELECTRONIC), Vol. 20, Iss. 4, 2014-08 ,pp. : 333-341

John Wiley & Sons Inc

Access to resources Recommend Favorite